FR2301244A1 - Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium - Google Patents

Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium

Info

Publication number
FR2301244A1
FR2301244A1 FR7604627A FR7604627A FR2301244A1 FR 2301244 A1 FR2301244 A1 FR 2301244A1 FR 7604627 A FR7604627 A FR 7604627A FR 7604627 A FR7604627 A FR 7604627A FR 2301244 A1 FR2301244 A1 FR 2301244A1
Authority
FR
France
Prior art keywords
pharmaceutical preparation
preparation containing
new pharmaceutical
magnesium aspartate
containing glutamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7604627A
Other languages
English (en)
Other versions
FR2301244B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VERLA PHARM
Original Assignee
VERLA PHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VERLA PHARM filed Critical VERLA PHARM
Publication of FR2301244A1 publication Critical patent/FR2301244A1/fr
Application granted granted Critical
Publication of FR2301244B1 publication Critical patent/FR2301244B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7604627A 1975-02-20 1976-02-19 Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium Granted FR2301244A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752507354 DE2507354A1 (de) 1975-02-20 1975-02-20 Pharmazeutische zubereitung

Publications (2)

Publication Number Publication Date
FR2301244A1 true FR2301244A1 (fr) 1976-09-17
FR2301244B1 FR2301244B1 (fr) 1979-07-20

Family

ID=5939402

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7604627A Granted FR2301244A1 (fr) 1975-02-20 1976-02-19 Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium

Country Status (4)

Country Link
US (1) US4041154A (fr)
DE (1) DE2507354A1 (fr)
FR (1) FR2301244A1 (fr)
GB (1) GB1498913A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2389378A1 (fr) * 1977-05-05 1978-12-01 Verla Pharm
EP0502765A1 (fr) * 1991-03-05 1992-09-09 Institut De Recherche Biologique S.A. Nouvelles compositions diététiques à base de lipides complexes phosphorés et leur utilisation dans les troubles du sommeil

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
EP0174980A4 (fr) * 1984-03-01 1987-10-08 Vernon Erk Utilisation d'un composé du manganèse dans la fabrication d'un médicament pour le traitement de l'hypothyroidisme.
AU599567B2 (en) * 1984-03-01 1990-07-26 Vernon Erk Method of treating memory disorders of the elderly
DE19809600C1 (de) * 1998-03-03 1999-10-21 Heberlein Fasertech Ag Garnbehandlungseinrichtung
DE19830310A1 (de) * 1998-07-07 2000-01-13 Riedel De Haen Gmbh Verfahren zur Abreicherung des Bromidgehaltes aus einer wäßrigen Bromid enthaltenden Lösung unter Verwendung von Wasserstoffperoxid
US6579905B1 (en) 2001-11-19 2003-06-17 Mcmains Michael B. Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with G-tubes or NG-tubes
US11369630B1 (en) * 2018-10-31 2022-06-28 Flex-It Mg Llc Formulations of magnesium chloride to treat muscle spasm, strain and sprain
SG11202110342UA (en) * 2019-03-26 2021-10-28 Winsantor Inc Topical formulations for treatment of peripheral neuropathies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836668A (en) * 1960-12-27 1974-09-17 Ferrer Labor Therapeutic composition and method of treating patients therewith
GB1141632A (en) * 1965-02-27 1969-01-29 Serono Ist Farm Improvements in or relating to glutamic acid derivatives
US3674882A (en) * 1968-05-17 1972-07-04 Sandoz Ag Dichloro trifluoromethyl phenyl lithium
US3778505A (en) * 1970-12-01 1973-12-11 Rech Etudes Therapeutiques Soc Lithium salt based pharmaceutical composition and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
UNLISTED DRUGS, 1974, PAGE 212C) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2389378A1 (fr) * 1977-05-05 1978-12-01 Verla Pharm
EP0502765A1 (fr) * 1991-03-05 1992-09-09 Institut De Recherche Biologique S.A. Nouvelles compositions diététiques à base de lipides complexes phosphorés et leur utilisation dans les troubles du sommeil
FR2673512A1 (fr) * 1991-03-05 1992-09-11 Inst Rech Biolog Sa Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil.

Also Published As

Publication number Publication date
GB1498913A (en) 1978-01-25
US4041154A (en) 1977-08-09
DE2507354A1 (de) 1976-09-09
FR2301244B1 (fr) 1979-07-20

Similar Documents

Publication Publication Date Title
BE870988A (fr) Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium
FR2296664A1 (fr) Dispersions d'urethanne contenant du silanol
BE828666A (fr) Procede pour la preparation d'une preparation pharmaceutique contenant du zinc convenant pour emplois medicaux
FR2411839B1 (fr) Derives de l'acide cephalosporanique, procedes pour leur preparation et composition pharmaceutique les contenant
FR2317933A1 (fr) Nouvelle composition pharmaceutique destinee a faciliter l'accouchement
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
FR2301244A1 (fr) Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium
GB1370973A (en) Therapeutic compositions
BE847943A (fr) Nouveau derive de l'acide retinoique totalement trans et composition pharmaceutique contenant ledit derive,
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
BE819294A (fr) Nouvelles compositions pharmaceutiques contenant de l'acide n-(2-furfuryl)-4-chloro-5-sulfamoyl-antranilique et leur procede de preparation
FR2291983A1 (fr) Purification de l'urokinase
BE825653A (fr) Compositions pharmaceutiques antibiotiques contenant le sel de sodium de l'acide 7- (d-2-formyloxy-2- phenylace tamido -3- 1-methyl-14-tetrazole-5-yl-thiomethyl)-3-cephem-40-carboxylique
FR2277591A1 (fr) Composition pharmaceutique pour la prevention et le traitement de l'alcoolisme
BE810145A (fr) Nouvelles compositions geriatriques contenant des derives de l'acide theophylline-7-acetique
BE884190A (fr) Compositions pharmaceutiques contenant des extraits de lierre grimpant
BE817070A (fr) Polybutadienes chlorobromes et copolymeres de butadiene et d'isoprene chlorobromes
BE841310R (fr) Explosifs contenant des bulles d'air stabilisees
BE820775A (fr) Compositions therapeutiques a base d'agents contenant un azote tertiaire et procede de preparation
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
BE824227A (fr) Nouveaux derives d'amidoxime, leur procede de prepatation ainsi que les compositions therapeutiques les contenant
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
FR2319605A1 (fr) Preparation de melanges d'alkylnaphtalenes
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
BE838880A (fr) Hydrazides d'acide (2-oxo-pyrrolidone-1)-acetique, procedes de preparation et preparations pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse